|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 233/64 | (2006.01) |
| C07D 401/04 | (2006.01) | ||
| A61K 31/4174 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3523283 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17787774.3 |
| Date of filing the European patent application | 2017-10-05 | |
| (97) | Date of publication of the European application | 2019-08-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-09 |
| (46) | Date of publication of the claims translation | 2021-07-12 |
| (86) | Number | PCT/US2017/055403 |
| Date | 2017-10-05 |
| (87) | Number | WO 2018/067860 |
| Date | 2018-04-12 |
| (30) | Number | Date | Country code |
| 201662404474 P | 2016-10-05 | US |
| (72) |
LAGU, Bharat , US
TRZASKA, Scott , US
|
| (73) |
Mitobridge, Inc. ,
1030 Massachusetts Avenue
Suite 200, Cambridge, MA 02138,
US
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | PPAR agonistų junginių kristalinės ir druskos formos |
| CRYSTALLINE AND SALT FORMS OF PPAR AGONIST COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2025-09-18 | 9 | 208.00 EUR |
| 2026-10-05 |